High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. (Q40978441)
Jump to navigation
Jump to search
scientific article published on January 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. |
scientific article published on January 1999 |
Statements
High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy (English)
Rosenberg SA
Perry-Lalley D
Dudley ME
1 January 1999